China Cancer Immunotherapy Market Research Report 2017

China Cancer Immunotherapy Market Research Report 2017

1 Cancer Immunotherapy Market Overview

1.1 Product Overview and Scope of Cancer Immunotherapy

1.2 Cancer Immunotherapy Segment by Type

1.2.1 China Production Market Share of Cancer Immunotherapy Type in 2015

1.2.2 Melanoma

1.2.3 Colorectal cancer

1.2.4 Prostate cancer

1.2.5 Head and neck cancer

1.2.6 Breast cancer

1.2.7 Lung cancer

1.2.8 Other

1.3 Applications of Cancer Immunotherapy

1.3.1 Cancer Immunotherapy Consumption Market Share by Application in 2015

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 China Market Size (Value) of Cancer Immunotherapy (2011-2021)

1.5 China Cancer Immunotherapy Status and Outlook

1.6 Government Policies

2 China Cancer Immunotherapy Market Competition by Manufacturers

2.1 China Cancer Immunotherapy Capacity, Production and Share by Manufacturers (2015 and 2016)

2.2 China Cancer Immunotherapy Revenue and Share by Manufacturers (2015 and 2016)

2.3 China Cancer Immunotherapy Average Price by Manufacturers (2015 and 2016)

2.4 Manufacturers Cancer Immunotherapy Manufacturing Base Distribution, Sales Area, Product Type

2.5 Cancer Immunotherapy Market Competitive Situation and Trends

2.5.1 Cancer Immunotherapy Market Concentration Rate

2.5.2 Cancer Immunotherapy Market Share of Top 3 and Top 5 Manufacturers

3 China Cancer Immunotherapy Manufacturers Profiles/Analysis

3.1 Amgen

3.1.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.1.2 Cancer Immunotherapy Product Type, Application and Specification

3.1.2.1 Melanoma

3.1.2.2 Colorectal cancer

3.1.3 Amgen Cancer Immunotherapy Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.1.4 Main Business/Business Overview

3.2 AstraZeneca

3.2.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.2.2 Cancer Immunotherapy Product Type, Application and Specification

3.2.2.1 Melanoma

3.2.2.2 Colorectal cancer

3.2.3 AstraZeneca 116 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.2.4 Main Business/Business Overview

3.3 F. Hoffman La-Roche

3.3.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.3.2 Cancer Immunotherapy Product Type, Application and Specification

3.3.2.1 Melanoma

3.3.2.2 Colorectal cancer

3.3.3 F. Hoffman La-Roche 128 Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.3.4 Main Business/Business Overview

3.4 Bayer AG

3.4.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.4.2 Cancer Immunotherapy Product Type, Application and Specification

3.4.2.1 Melanoma

3.4.2.2 Colorectal cancer

3.4.3 Bayer AG Jan Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.4.4 Main Business/Business Overview

3.5 Bristol-Myers Squibb

3.5.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.5.2 Cancer Immunotherapy Product Type, Application and Specification

3.5.2.1 Melanoma

3.5.2.2 Colorectal cancer

3.5.3 Bristol-Myers Squibb Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.5.4 Main Business/Business Overview

3.6 Eli Lilly and Company

3.6.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.6.2 Cancer Immunotherapy Product Type, Application and Specification

3.6.2.1 Melanoma

3.6.2.2 Colorectal cancer

3.6.3 Eli Lilly and Company Million USD Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.6.4 Main Business/Business Overview

3.7 Janssen Global Services

3.7.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.7.2 Cancer Immunotherapy Product Type, Application and Specification

3.7.2.1 Melanoma

3.7.2.2 Colorectal cancer

3.7.3 Janssen Global Services Pharma & Healthcare Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.7.4 Main Business/Business Overview

3.8 Merck

3.8.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.8.2 Cancer Immunotherapy Product Type, Application and Specification

3.8.2.1 Melanoma

3.8.2.2 Colorectal cancer

3.8.3 Merck Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.8.4 Main Business/Business Overview

3.9 Novartis

3.9.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.9.2 Cancer Immunotherapy Product Type, Application and Specification

3.9.2.1 Melanoma

3.9.2.2 Colorectal cancer

3.9.3 Novartis Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.9.4 Main Business/Business Overview

3.10 Pfizer

3.10.1 Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

3.10.2 Cancer Immunotherapy Product Type, Application and Specification

3.10.2.1 Melanoma

3.10.2.2 Colorectal cancer

3.10.3 Pfizer Capacity, Production, Revenue, Price and Gross Margin (2015 and 2016)

3.10.4 Main Business/Business Overview

3.11 Seattle Genetics

3.12 Peregrine Pharmaceuticals

3.13 Viralytics Ltd

3.14 Immunomedics

4 China Cancer Immunotherapy Capacity, Production, Revenue, Consumption, Export and Import (2011-2016)

4.1 China Cancer Immunotherapy Capacity, Production and Growth (2011-2016)

4.2 China Cancer Immunotherapy Revenue and Growth (2011-2016)

4.3 China Cancer Immunotherapy Production, Consumption, Export and Import (2011-2016)

5 China Cancer Immunotherapy Production, Revenue (Value), Price Trend by Type

5.1 China Cancer Immunotherapy Production and Market Share by Type (2011-2016)

5.2 China Cancer Immunotherapy Revenue and Market Share by Type (2011-2016)

5.3 China Cancer Immunotherapy Price by Type (2011-2016)

5.4 China Cancer Immunotherapy Production Growth by Type (2011-2016)

6 China Cancer Immunotherapy Market Analysis by Application

6.1 China Cancer Immunotherapy Consumption and Market Share by Application (2011-2016)

6.2 China Cancer Immunotherapy Consumption Growth Rate by Application (2011-2016)

6.3 Market Drivers and Opportunities

6.3.1 Potential Application

6.3.2 Emerging Markets/Countries

7 ChinaCancer Immunotherapy Market Analysis by Regions (Provinces)

7.1 China Cancer Immunotherapy Production, Production Value and Price by Regions (Provinces)(2011-2016)

7.1.1 China Cancer Immunotherapy Production and Market Share by Regions (Provinces)(2011-2016)

7.1.2 China Cancer Immunotherapy Production Value and Market Share by Regions (Provinces)(2011-2016)

7.1.3 China Cancer Immunotherapy Sales Price by Regions (Provinces)(2011-2016)

7.2 China Cancer Immunotherapy Consumption by Regions (Provinces)(2011-2016)

7.3 China Cancer Immunotherapy Production, Consumption, Export and Import (2011-2016)

8 Cancer Immunotherapy Manufacturing Cost Analysis

8.1 Cancer Immunotherapy Key Raw Materials Analysis

8.1.1 Key Raw Materials

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Proportion of Manufacturing Cost Structure

8.2.1 Raw Materials

8.2.2 Labor Cost

8.2.3 Manufacturing Expenses

8.3 Manufacturing Process Analysis of Cancer Immunotherapy

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Cancer Immunotherapy Industrial Chain Analysis

9.2 Upstream Raw Materials Sourcing

9.3 Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015

9.4 Downstream Buyers

10 Marketing Strategy Analysis, Distributors/Traders

10.1 Marketing Channel

10.1.1 Direct Marketing

10.1.2 Indirect Marketing

10.1.3 Marketing Channel Development Trend

10.2 Market Positioning

10.2.1 Pricing Strategy

10.2.2 Brand Strategy

10.2.3 Target Client

10.3 Distributors/Traders List

11 Market Effect Factors Analysis

11.1 Technology Progress/Risk

11.1.1 Substitutes Threat

11.1.2 Technology Progress in Related Industry

11.2 Consumer Needs/Customer Preference Change

11.3 Economic/Political Environmental Change

12 China Cancer Immunotherapy Market Forecast (2016-2021)

12.1 China Cancer Immunotherapy Capacity, Production, Revenue Forecast (2016-2021)

12.2 China Cancer Immunotherapy Production, Import, Export and Consumption Forecast (2016-2021)

12.3 China Cancer Immunotherapy Production Forecast by Type (2016-2021)

12.4 China Cancer Immunotherapy Consumption Forecast by Application (2016-2021)

12.5 China Cancer Immunotherapy Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)

12.5.1 China Cancer Immunotherapy Production Forecast by Regions (Provinces)(2016-2021)

12.5.2 China Cancer Immunotherapy Consumption Forecast by Regions (Provinces)(2016-2021)

12.5.3 China Cancer Immunotherapy Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)

12.6 Cancer Immunotherapy Price Forecast (2016-2021)

13 Research Findings and Conclusion

14 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Cancer Immunotherapy

Figure China Production Market Share of Cancer Immunotherapy by Type in 2015

Figure Product Picture of Melanoma

Table Major Manufacturers of Melanoma

Figure Product Picture of Colorectal cancer

Table Major Manufacturers of Colorectal cancer

Figure Product Picture of Prostate cancer

Table Major Manufacturers of Prostate cancer

Figure Product Picture of Head and neck cancer

Table Major Manufacturers of Head and neck cancer

Figure Product Picture of Breast cancer

Table Major Manufacturers of Breast cancer

Figure Product Picture of Lung cancer

Table Major Manufacturers of Lung cancer

Figure Product Picture of Other

Table Major Manufacturers of Other

Table Cancer Immunotherapy Consumption Market Share by Application in 2015

Figure Hospitals Examples

Figure Clinics Examples

Figure Others Examples

Figure China Cancer Immunotherapy Revenue (Million USD) and Growth Rate (2011-2021)

Table China Cancer Immunotherapy Capacity of Key Manufacturers (2015 and 2016)

Table China Cancer Immunotherapy Capacity Market Share of Key Manufacturers (2015 and 2016)

Figure China Cancer Immunotherapy Capacity of Key Manufacturers in 2015

Figure China Cancer Immunotherapy Capacity of Key Manufacturers in 2016

Table China Cancer Immunotherapy Production of Key Manufacturers (2015 and 2016)

Table China Cancer Immunotherapy Production Share by Manufacturers (2015 and 2016)

Figure 2015 Cancer Immunotherapy Production Share by Manufacturers

Figure 2016 Cancer Immunotherapy Production Share by Manufacturers

Table China Cancer Immunotherapy Revenue (Million USD) by Manufacturers (2015 and 2016)

Table China Cancer Immunotherapy Revenue Share by Manufacturers (2015 and 2016)

Table 2015 China Cancer Immunotherapy Revenue Share by Manufacturers

Table 2016 China Cancer Immunotherapy Revenue Share by Manufacturers

Table China Market Cancer Immunotherapy Average Price of Key Manufacturers (2015 and 2016)

Figure China Market Cancer Immunotherapy Average Price of Key Manufacturers in 2015

Table Manufacturers Cancer Immunotherapy Manufacturing Base Distribution and Sales Area

Table Manufacturers Cancer Immunotherapy Product Type

Figure Cancer Immunotherapy Market Share of Top 3 Manufacturers

Figure Cancer Immunotherapy Market Share of Top 5 Manufacturers

Table Amgen Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Amgen Cancer Immunotherapy Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Amgen Cancer Immunotherapy Market Share (2011-2016)

Table AstraZeneca Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table AstraZeneca Cancer Immunotherapy Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure AstraZeneca Cancer Immunotherapy Market Share (2011-2016)

Table F. Hoffman La-Roche Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table F. Hoffman La-Roche Cancer Immunotherapy Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure F. Hoffman La-Roche Cancer Immunotherapy Market Share (2011-2016)

Table Bayer AG Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bayer AG Cancer Immunotherapy Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Bayer AG Cancer Immunotherapy Market Share (2011-2016)

Table Bristol-Myers Squibb Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Bristol-Myers Squibb Cancer Immunotherapy Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Bristol-Myers Squibb Cancer Immunotherapy Market Share (2011-2016)

Table Eli Lilly and Company Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Eli Lilly and Company Cancer Immunotherapy Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Eli Lilly and Company Cancer Immunotherapy Market Share (2011-2016)

Table Janssen Global Services Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Janssen Global Services Cancer Immunotherapy Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Janssen Global Services Cancer Immunotherapy Market Share (2011-2016)

Table Merck Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Merck Cancer Immunotherapy Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Merck Cancer Immunotherapy Market Share (2011-2016)

Table Novartis Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Novartis Cancer Immunotherapy Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Novartis Cancer Immunotherapy Market Share (2011-2016)

Table Pfizer Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Pfizer Cancer Immunotherapy Capacity, Production, Revenue, Price and Gross Margin (2011-2016)

Figure Pfizer Cancer Immunotherapy Market Share (2011-2016)

Table Seattle Genetics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Peregrine Pharmaceuticals Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Viralytics Ltd Basic Information, Manufacturing Base, Sales Area and Its Competitors

Table Immunomedics Basic Information, Manufacturing Base, Sales Area and Its Competitors

Figure China Cancer Immunotherapy Capacity, Production and Growth (2011-2016)

Figure China Cancer Immunotherapy Revenue (Million USD) and Growth (2011-2016)

Table China Cancer Immunotherapy Production, Consumption, Export and Import (2011-2016)

Table China Cancer Immunotherapy Production by Type (2011-2016)

Table China Cancer Immunotherapy Production Share by Type (2011-2016)

Figure Production Market Share of Cancer Immunotherapy by Type (2011-2016)

Figure 2015 Production Market Share of Cancer Immunotherapy by Type

Table China Cancer Immunotherapy Revenue by Type (2011-2016)

Table China Cancer Immunotherapy Revenue Share by Type (2011-2016)

Figure Production Revenue Share of Cancer Immunotherapy by Type (2011-2016)

Figure 2015 Revenue Market Share of Cancer Immunotherapy by Type

Table China Cancer Immunotherapy Price by Type (2011-2016)

Figure China Cancer Immunotherapy Production Growth by Type (2011-2016)

Table China Cancer Immunotherapy Consumption by Application (2011-2016)

Table China Cancer Immunotherapy Consumption Market Share by Application (2011-2016)

Figure China Cancer Immunotherapy Consumption Market Share by Application in 2015

Table China Cancer Immunotherapy Consumption Growth Rate by Application (2011-2016)

Figure China Cancer Immunotherapy Consumption Growth Rate by Application (2011-2016)

Table China Cancer Immunotherapy Production by Regions (Provinces)(2011-2016)

Table China Cancer Immunotherapy Production Market Share by Regions (Provinces)(2011-2016)

Table China Cancer Immunotherapy Production Value by Regions (Provinces)(2011-2016)

Table China Cancer Immunotherapy Production Value Market Share by Regions (Provinces)(2011-2016)

Table China Cancer Immunotherapy Sales Price by Regions (Provinces)(2011-2016)

Table China Cancer Immunotherapy Consumption by Regions (Provinces)(2011-2016)

Table China Cancer Immunotherapy Consumption Market Share by Regions (Provinces)(2011-2016)

Table China Cancer Immunotherapy Production, Consumption, Export and Import (2011-2016)

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Cancer Immunotherapy

Figure Manufacturing Process Analysis of Cancer Immunotherapy

Figure Cancer Immunotherapy Industrial Chain Analysis

Table Raw Materials Sources of Cancer Immunotherapy Major Manufacturers in 2015

Table Major Buyers of Cancer Immunotherapy

Table Distributors/Traders List

Figure China Cancer Immunotherapy Capacity, Production and Growth Rate Forecast (2016-2021)

Figure China Cancer Immunotherapy Revenue and Growth Rate Forecast (2016-2021)

Table China Cancer Immunotherapy Production, Import, Export and Consumption Forecast (2016-2021)

Table China Cancer Immunotherapy Production Forecast by Type (2016-2021)

Table China Cancer Immunotherapy Consumption Forecast by Application (2016-2021)

Table China Cancer Immunotherapy Production Forecast by Regions (Provinces)(2016-2021)

Table China Cancer Immunotherapy Consumption Forecast by Regions (Provinces)(2016-2021)

Table China Cancer Immunotherapy Production, Consumption, Import and Export Forecast by Regions (Provinces)(2016-2021)